'An Insight Into The Secondary Metabolite Profile Of Bergenia Ligulata Rhizome Showed Bergenin As The Most Potent Antilithiatic Agent | 40636
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

2nd International Conference on Biotechnology and Healthcare

Auckland, New Zealand

6th International Conference on Vaccines and Immunology

Geneva, Switzerland

3rd European Congress on Virology

Geneva, Switzerland
Google scholar citation report
Citations : 1600

Journal of Biotechnology & Biomaterials received 1600 citations as per google scholar report

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Access to Global Online Research in Agriculture (AGORA)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

'An insight into the secondary metabolite profile of Bergenia ligulata rhizome showed Bergenin as the most potent antilithiatic agent

6th World Congress on Biotechnology

Deepika, Sanjeev Puri and Surinder Kumar Singla

Panjab University, India

ScientificTracks Abstracts: J Biotechnol Biomater

DOI: 10.4172/2155-952X.C1.043

The current lack in regimen of management of renal tissue calcification and the side-effects of synthesized allopathic medicine shifted the focus of scientists towards the traditional system of herbal therapy. Bergenia ligulata is referred by the ayurvedic system for treatment of kidney stone since decades but a scientific study indicating its metabolite responsible for antilithiatic activity is lacking. The aim of the study was to isolate the most potent antilithiatic metabolite from the rhizome of B. ligulata. In order to identify this, the crude extract of rhizome was fractionated using column chromatography guided by in vitro calcium oxalate (CaOx) crystal growth inhibitory activity. The active fraction was characterized via LC-MS, FTIR and NMR. Further, the in vitro antioxidant potential of purified molecule was also assessed. In vivo activity of the metabolite was evaluated in hyperoxaluric rats given 0.4% ethylene glycol (EG) and 1.0% ammonium chloride (NH4Cl) for 9 days. Activity guided fractionation led to the isolation of most potent antilithiatic metabolite from the rhizome of B. ligulata and spectroscopic analysis revealed it as bergenin. At a dose of 10 mg/kg body weight of the treated rat, it protected against deleterious effects of lithogenic treatment. Bergenin maintained oxidant/antioxidant balance in hyperoxaluric rats, thus mechanistic insight of its antilithiatic activity was attributed to its antioxidant capability. The results of the present study provide significant evidence that bergenin is an active component present in the rhizome of B. ligulata for managing CaOx calculi ameliorating renal injury.

Deepika Aggarwal is currently pursuing her PhD at the Department of Biochemistry, Panjab University. The aim of her research work is to investigate the antilithiatic potential of B. ligulata rhizome with a plunge to isolate the active metabolites responsible for this activity. She has got two publications with one original research article in Journal of Ethnopharmacology and another being a review to her credit. She has presented her work at many national and international conferences.

Email: [email protected]